These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8861533

  • 1. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
    Marklein G.
    Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533
    [Abstract] [Full Text] [Related]

  • 2. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
    Whitby M, Angus L, Nimmo G, Hill V.
    Chemotherapy; 1996 Mar; 42(6):468-72. PubMed ID: 8957583
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
    Chuchalin AG, Novikov IuK, Avdeev SN, Belevskiĭ AS.
    Antibiot Khimioter; 1997 Mar; 42(6):34-8. PubMed ID: 9313057
    [Abstract] [Full Text] [Related]

  • 4. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA, Todd PA, Peters DH.
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [Abstract] [Full Text] [Related]

  • 5. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [Abstract] [Full Text] [Related]

  • 6. [A clinical study in the treatment of acute bacterial infections with fleroxacin].
    Hou J, Li J, Cui H.
    Zhonghua Nei Ke Za Zhi; 1996 Oct; 35(10):663-7. PubMed ID: 9592325
    [Abstract] [Full Text] [Related]

  • 7. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A.
    Am J Med; 1993 Mar 22; 94(3A):89S-96S. PubMed ID: 8452189
    [Abstract] [Full Text] [Related]

  • 8. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S.
    Chest; 1991 Dec 22; 100(6):1497-502. PubMed ID: 1659975
    [Abstract] [Full Text] [Related]

  • 9. Fleroxacin overview.
    Naber KG.
    Chemotherapy; 1996 Mar 22; 42 Suppl 1():1-9. PubMed ID: 8861529
    [Abstract] [Full Text] [Related]

  • 10. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar 22; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G, Scorer HJ, Carnegie CM.
    J Antimicrob Chemother; 1992 Jul 22; 30(1):89-100. PubMed ID: 1331020
    [Abstract] [Full Text] [Related]

  • 12. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ, Lentino JR.
    Clin Ther; 1992 Jul 22; 14(4):595-602. PubMed ID: 1525793
    [Abstract] [Full Text] [Related]

  • 13. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A, Naber KG, Bischoff W, Kullmann K.
    J Urol; 1997 Oct 22; 158(4):1494-9. PubMed ID: 9302150
    [Abstract] [Full Text] [Related]

  • 14. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K.
    Am J Med; 1993 Mar 22; 94(3A):108S-113S. PubMed ID: 8452165
    [Abstract] [Full Text] [Related]

  • 15. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
    Drehobl M, Koenig L, Barker M, St Clair P, Maladorno D.
    Chemotherapy; 1997 Mar 22; 43(5):378-84. PubMed ID: 9309373
    [Abstract] [Full Text] [Related]

  • 16. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D.
    Int J Antimicrob Agents; 2004 Jun 22; 23(6):596-605. PubMed ID: 15194131
    [Abstract] [Full Text] [Related]

  • 17. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
    Torres A, Bauer TT, León-Gil C, Castillo F, Alvarez-Lerma F, Martínez-Pellús A, Leal-Noval SR, Nadal P, Palomar M, Blanquer J, Ros F.
    Thorax; 2000 Dec 22; 55(12):1033-9. PubMed ID: 11083889
    [Abstract] [Full Text] [Related]

  • 18. Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
    Farkas SA.
    Am J Med; 1993 Mar 22; 94(3A):142S-149S. PubMed ID: 8452171
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
    Davey PG.
    Am J Med; 1991 Dec 30; 91(6A):101S-105S. PubMed ID: 1662877
    [Abstract] [Full Text] [Related]

  • 20. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group.
    Ragnar Norrby S.
    J Antimicrob Chemother; 1997 Apr 30; 39(4):499-508. PubMed ID: 9145823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.